<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">114</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2017-4-4-17-23</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CYCLOPHILIN A: STRUCTURE AND FUNCTIONS</article-title><trans-title-group xml:lang="ru"><trans-title>ЦИКЛОФИЛИН А: СТРОЕНИЕ И ФУНКЦИИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kalinina</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Калинина</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>Анастасия Андреевна Калинина.</p><p>115478 Москва, Каширское шоссе, 24</p></bio><email>aakalinina89@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khromykh</surname><given-names>L. M.</given-names></name><name xml:lang="ru"><surname>Хромых</surname><given-names>Л. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kazansky</surname><given-names>D. B.</given-names></name><name xml:lang="ru"><surname>Казанский</surname><given-names>Д. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2017</year></pub-date><volume>4</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>17</fpage><lpage>23</lpage><history><date date-type="received" iso-8601-date="2017-12-02"><day>02</day><month>12</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-12-02"><day>02</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Kalinina A.A., Khromykh L.M., Kazansky D.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Калинина А.А., Хромых Л.М., Казанский Д.Б.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Kalinina A.A., Khromykh L.M., Kazansky D.B.</copyright-holder><copyright-holder xml:lang="ru">Калинина А.А., Хромых Л.М., Казанский Д.Б.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/114">https://umo.abvpress.ru/jour/article/view/114</self-uri><abstract xml:lang="en"><p>Cyclophilins belong to a large family of ancient conservative proteins with peptidyl-prolyl-cis-trans isomerase activity. The main member of this family – cyclophilin A – was discovered as an intracellular ligand for cyclosporine A. Further investigations revealed a wide range of functions of cyclophilin A. Cyclophilin A is involved in T-cell signaling, it takes part in folding, assembly and intracellular transport of proteins, as well as acts as an antioxidant. Different cell types secrete cyclophilin A under infection or oxidative stress. Cyclophilin A is one of the main factors involved in inflammation and pathogenesis of autoimmune, cardiovascular and other diseases. This protein is thought to take part in tumor progression. In this review we describe the structure of cyclophilin A and its main known functions in health and disease.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>cyclophilin A</kwd><kwd>peptidyl-prolyl isomerase</kwd><kwd>CD147</kwd><kwd>chemoattractant</kwd><kwd>cyclosporine A</kwd><kwd>inflammation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>циклофилин А</kwd><kwd>пептидил-пролил-изомераза</kwd><kwd>CD147</kwd><kwd>хемоаттрактант</kwd><kwd>циклоспорин А</kwd><kwd>воспаление</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Handschumacher R.E., Harding M.W., Rice J. et. al. Cyclophilin: a specific cytosolic binding protein for cyclosporine A. Science 1984;226(4674):544–6.</mixed-citation><mixed-citation xml:lang="ru">Handschumacher R.E., Harding M.W., Rice J. et. al. Cyclophilin: a specific cytosolic binding protein for cyclosporine A. Science 1984;226(4674):544–6.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Fischer G., Bang H., Mech C. Detection of enzyme catalysis for cis-trans isomerization of peptide bonds using proline containing peptides as substrates. Biomed Biochim Acta 1984;43:1101–12.</mixed-citation><mixed-citation xml:lang="ru">Fischer G., Bang H., Mech C. Detection of enzyme catalysis for cis-trans isomerization of peptide bonds using proline containing peptides as substrates. Biomed Biochim Acta 1984;43:1101–12.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Fischer G., Wittmann-Liebold B., Lang K. et al. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989;337(6206):476–8.</mixed-citation><mixed-citation xml:lang="ru">Fischer G., Wittmann-Liebold B., Lang K. et al. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989;337(6206):476–8.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-truns isomerase is the cyclosporin A-binding protein cyclophilin. Nаture 1989;337(6206):473–5.</mixed-citation><mixed-citation xml:lang="ru">Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-truns isomerase is the cyclosporin A-binding protein cyclophilin. Nаture 1989;337(6206):473–5.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Wang P., Heitman J. Cyclophilins. Genome Biology 2005;6(7):226.</mixed-citation><mixed-citation xml:lang="ru">Wang P., Heitman J. Cyclophilins. Genome Biology 2005;6(7):226.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Honga F., Leeb J., Piaoa Y.J. et al. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity. Biochem Biophys Res Commun 2004;316(4):1073–80.</mixed-citation><mixed-citation xml:lang="ru">Honga F., Leeb J., Piaoa Y.J. et al. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity. Biochem Biophys Res Commun 2004;316(4):1073–80.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Song F., Zhang X., Ren X.B. et al Cyclophilin A (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147. J Biol Chem 2011;286(10):8197–203.</mixed-citation><mixed-citation xml:lang="ru">Song F., Zhang X., Ren X.B. et al Cyclophilin A (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147. J Biol Chem 2011;286(10):8197–203.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Bahmed K., Henry C., Holliday M. et al. Extracellular cyclophilin A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B. Cancer Cell Int 2012;12(1):19.</mixed-citation><mixed-citation xml:lang="ru">Bahmed K., Henry C., Holliday M. et al. Extracellular cyclophilin A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B. Cancer Cell Int 2012;12(1):19.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Zhao Y., Chen Y., Schutkowski M. et al. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 1997;5(1):139–46.</mixed-citation><mixed-citation xml:lang="ru">Zhao Y., Chen Y., Schutkowski M. et al. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 1997;5(1):139–46.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Ryffel B., Woerly G., Greiner B. et al. Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 1991;72(3):399–404.</mixed-citation><mixed-citation xml:lang="ru">Ryffel B., Woerly G., Greiner B. et al. Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 1991;72(3):399–404.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Doyle V., Virji S., Crompton M. Evidence that cyclophilin A protects cells against oxidative stress. Biochem J 1999;341 (Pt 1):127–32.</mixed-citation><mixed-citation xml:lang="ru">Doyle V., Virji S., Crompton M. Evidence that cyclophilin A protects cells against oxidative stress. Biochem J 1999;341 (Pt 1):127–32.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Seko Y., Fujimura T., Taka H. et al. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 2004;317(1):162–8.</mixed-citation><mixed-citation xml:lang="ru">Seko Y., Fujimura T., Taka H. et al. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 2004;317(1):162–8.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Jäschke A., Mi H., Tropschug M. Human T cell cyclophilin18 binds to thiol-specific antioxidant protein Aop1 and stimulates its activity. J Mol Biol 1998;277(4):763–9.</mixed-citation><mixed-citation xml:lang="ru">Jäschke A., Mi H., Tropschug M. Human T cell cyclophilin18 binds to thiol-specific antioxidant protein Aop1 and stimulates its activity. J Mol Biol 1998;277(4):763–9.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Hu B.R., Martone M.E., Jones Y.Z., Liu C.L. Protein aggregation after transient cerebral ischemia. J Neurosci 2000;20(9):3191–9.</mixed-citation><mixed-citation xml:lang="ru">Hu B.R., Martone M.E., Jones Y.Z., Liu C.L. Protein aggregation after transient cerebral ischemia. J Neurosci 2000;20(9):3191–9.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Colgan J., Asmal M., Neagu M. et al. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 2004;21(2):189–201.</mixed-citation><mixed-citation xml:lang="ru">Colgan J., Asmal M., Neagu M. et al. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 2004;21(2):189–201.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Sherry B., Yarlett N., Strupp A., Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA 1992;89(8):3511–5.</mixed-citation><mixed-citation xml:lang="ru">Sherry B., Yarlett N., Strupp A., Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA 1992;89(8):3511–5.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Obchoei S., Wongkhan S., Wongkham C. et al. Cyclophilin A. potential functions and therapeutic target for human cancer. Med Sci Monit 2009;15(11):221–32.</mixed-citation><mixed-citation xml:lang="ru">Obchoei S., Wongkhan S., Wongkham C. et al. Cyclophilin A. potential functions and therapeutic target for human cancer. Med Sci Monit 2009;15(11):221–32.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Suzuki J., Jin Z.G., Meoli D.F. et al. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 2006;98(6):811–7.</mixed-citation><mixed-citation xml:lang="ru">Suzuki J., Jin Z.G., Meoli D.F. et al. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 2006;98(6):811–7.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Khromykh L.M., Kulikova N.L., Anfalova T.V. et al. Cyclophilin A produced by thymocytes regulates the migration of murine bone marrow cells. Cell Immunol 2007;249(1):46–53.</mixed-citation><mixed-citation xml:lang="ru">Khromykh L.M., Kulikova N.L., Anfalova T.V. et al. Cyclophilin A produced by thymocytes regulates the migration of murine bone marrow cells. Cell Immunol 2007;249(1):46–53.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Bharadwaj U., Zhang R., Yang H. et al. Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation. J Surg Res 2005;127(1):29–38.</mixed-citation><mixed-citation xml:lang="ru">Bharadwaj U., Zhang R., Yang H. et al. Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation. J Surg Res 2005;127(1):29–38.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Xu Q., Leiva M.C., Fischkoff S.A. et al. Leukocyte chemotactic activity of cyclophilin. J Biol Chem 1992;267(17):11968–71.</mixed-citation><mixed-citation xml:lang="ru">Xu Q., Leiva M.C., Fischkoff S.A. et al. Leukocyte chemotactic activity of cyclophilin. J Biol Chem 1992;267(17):11968–71.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Damsker J.M., Bukrinsky M.I., Constan S.L. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J Leukoc Biol 2007;82(3):613–8.</mixed-citation><mixed-citation xml:lang="ru">Damsker J.M., Bukrinsky M.I., Constan S.L. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J Leukoc Biol 2007;82(3):613–8.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Gwinn W.M., Damsker J.M., Falahati R. et al. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J Immunol 2006;177(7):4870–9.</mixed-citation><mixed-citation xml:lang="ru">Gwinn W.M., Damsker J.M., Falahati R. et al. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J Immunol 2006;177(7):4870–9.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Arora K., Gwinn W.M., Bower M.A. et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 2005;175(1): 517–22.</mixed-citation><mixed-citation xml:lang="ru">Arora K., Gwinn W.M., Bower M.A. et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 2005;175(1): 517–22.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Nabeshima K., Iwasaki H., Koga K. et al. EMMPRIN (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006;56(7): 359–67.</mixed-citation><mixed-citation xml:lang="ru">Nabeshima K., Iwasaki H., Koga K. et al. EMMPRIN (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006;56(7): 359–67.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Yurchenko V., Constant S., Bukrinsky M. Dealing with the family: CD147 interactions with cyclophilins. Immunology 2006;117(3):301–9.</mixed-citation><mixed-citation xml:lang="ru">Yurchenko V., Constant S., Bukrinsky M. Dealing with the family: CD147 interactions with cyclophilins. Immunology 2006;117(3):301–9.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Coste I., Gauchat J.F., Wilson A. et al. Unavailability of CD147 leads to selective erythrocyte trapping in the spleen. Blood 2001;97(12):3984–8.</mixed-citation><mixed-citation xml:lang="ru">Coste I., Gauchat J.F., Wilson A. et al. Unavailability of CD147 leads to selective erythrocyte trapping in the spleen. Blood 2001;97(12):3984–8.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Konttinen Y.T., Li T.F., Mandelin J. et al. Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum 2000;43(2):275–80.</mixed-citation><mixed-citation xml:lang="ru">Konttinen Y.T., Li T.F., Mandelin J. et al. Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum 2000;43(2):275–80.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Damsker J.M., Okwumabua I., Bukrinsky M.I., Constant S.L. Contribution of cyclophilin-CD147 interactions in rheumatoid arthritis. J Immunol 2006;176:47.</mixed-citation><mixed-citation xml:lang="ru">Damsker J.M., Okwumabua I., Bukrinsky M.I., Constant S.L. Contribution of cyclophilin-CD147 interactions in rheumatoid arthritis. J Immunol 2006;176:47.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Nigro P., Pompilio G., Capogrossi M.C. Cyclophilin A: a key player for human disease. Cell Death Dis 2013;4:e888.</mixed-citation><mixed-citation xml:lang="ru">Nigro P., Pompilio G., Capogrossi M.C. Cyclophilin A: a key player for human disease. Cell Death Dis 2013;4:e888.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Iacono K.T., Brown A.L., Greene M.I., Saouaf S.J. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007;83(3):283–95.</mixed-citation><mixed-citation xml:lang="ru">Iacono K.T., Brown A.L., Greene M.I., Saouaf S.J. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007;83(3):283–95.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Yang H., Chen J., Yang J. et al. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. Biochem Biophys Res Commun 2007;361(3):763–7.</mixed-citation><mixed-citation xml:lang="ru">Yang H., Chen J., Yang J. et al. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. Biochem Biophys Res Commun 2007;361(3):763–7.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Li M., Zhai Q., Bharadwaj U. et al. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 2006;106(10):2284–94.</mixed-citation><mixed-citation xml:lang="ru">Li M., Zhai Q., Bharadwaj U. et al. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 2006;106(10):2284–94.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Semba S., Huebner K. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol Cancer Res 2006;4(8):529–38.</mixed-citation><mixed-citation xml:lang="ru">Semba S., Huebner K. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol Cancer Res 2006;4(8):529–38.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Li Z., Zhao X., Bai S. et al. Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 2008;7(10):1810–23.</mixed-citation><mixed-citation xml:lang="ru">Li Z., Zhao X., Bai S. et al. Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 2008;7(10):1810–23.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Schlegel A.J., Redzic J.S., Porter C.C. et al. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. J Mol Biol 2009;391(3):518–35.</mixed-citation><mixed-citation xml:lang="ru">Schlegel A.J., Redzic J.S., Porter C.C. et al. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. J Mol Biol 2009;391(3):518–35.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Gabison E.E., Hoang-Xuan T., Mauviel A., Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005;87(3–4):361–8.</mixed-citation><mixed-citation xml:lang="ru">Gabison E.E., Hoang-Xuan T., Mauviel A., Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005;87(3–4):361–8.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38. Davies B., Miles D.W., Happerfield L.C. et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67(5):1126–31.</mixed-citation><mixed-citation xml:lang="ru">Davies B., Miles D.W., Happerfield L.C. et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67(5):1126–31.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2(3):161–74.</mixed-citation><mixed-citation xml:lang="ru">Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2(3):161–74.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40. Tang Y., Nakada M.T., Kesavan P. et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005;65(8):3193–9.</mixed-citation><mixed-citation xml:lang="ru">Tang Y., Nakada M.T., Kesavan P. et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005;65(8):3193–9.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">41. Choi K.J., Piao Y.J., Lim M.J. et al. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxiaand cisplatin-induced cell death. Cancer Res 2007;67(8):3654–62.</mixed-citation><mixed-citation xml:lang="ru">Choi K.J., Piao Y.J., Lim M.J. et al. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxiaand cisplatin-induced cell death. Cancer Res 2007;67(8):3654–62.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">42. Chen S., Zhang M., Ma H. et al. Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemother Pharmacol 2008;61(3):459–69.</mixed-citation><mixed-citation xml:lang="ru">Chen S., Zhang M., Ma H. et al. Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemother Pharmacol 2008;61(3):459–69.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">43. Grigoryeva E.S., Cherdyntseva N.V., Karbyshev M.S. et al. Expression of cyclophilin A in gastric adenocarcinoma patients and its inverse association with local relapses and distant metastasis. Pathol Oncol Res 2014;20(2):467–73.</mixed-citation><mixed-citation xml:lang="ru">Grigoryeva E.S., Cherdyntseva N.V., Karbyshev M.S. et al. Expression of cyclophilin A in gastric adenocarcinoma patients and its inverse association with local relapses and distant metastasis. Pathol Oncol Res 2014;20(2):467–73.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
